breseq  version 0.33.1  revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
  seq id position ref new freq score (cons/poly) reads annotation genes product
*USA300TCH1516_ALE111,5160CA51.3% 15.9 / 68.8 39Q196K (CAA→AAA) USA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE111,5120AG47.6% 11.2 / 55.4 42S194S (TCA→TCGUSA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE512,6430AG45.7% 13.7 / 91.6 70intergenic (+711/‑6052)recR/speA_2Recombination protein RecR/Arginine decarboxylase
*USA300TCH1516_ALE111,5600TC24.0% 48.1 / 12.1 25R210R (CGT→CGCUSA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE941,7440CT21.7% 97.8 / 19.4 46D96N (GAT→AAT) ptlENeopentalenolactone D synthase
*USA300TCH1516_ALE2,565,4230AG21.1% 72.8 / 18.5 38T517T (ACA→ACGnhaK_2Sodium, potassium, lithium and rubidium/H(+) antiporter
*USA300TCH1516_ALE252,1410TG20.0% 41.1 / 12.0 25S140A (TCA→GCA) gfo_2Glucose‑‑fructose oxidoreductase

Marginal new junction evidence (sorted from low to high skew)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? USA300TCH1516_ALE 2085296 =29 (0.830)4 (0.130) 4/252 3.2 14.8% coding (173/201 nt) hlb_1 Phospholipase C
?USA300TCH1516_ALE = 2128343 20 (0.640)coding (1/825 nt) hlb_2 Phospholipase C
* ? USA300TCH1516_ALE = 80092828 (0.800)4 (0.120) 4/266 3.4 14.9% intergenic (+62/‑289) hisC_1/USA300HOU_RS03915 Histidinol‑phosphate aminotransferase/Putative 5'(3')‑deoxyribonucleotidase
?USA300TCH1516_ALE 801948 = 19 (0.570)intergenic (+189/+435) USA300HOU_RS03915/USA300HOU_RS03920 Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase
* ? CP000731 4323 =96 (0.950)9 (0.020) 5/266 9.9 1.7% intergenic (+288/‑177) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
?NC_012417 2035 = 937 (1.060)intergenic (+268/+58) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 2276 =110 (1.090)9 (0.020) 5/266 9.9 1.7% intergenic (+56/+112) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?NC_012417 2035 = 937 (1.060)intergenic (+268/+58) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 4294 =95 (0.940)10 (0.020) 4/264 10.5 2.1% intergenic (+259/‑206) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
?NC_012417 2073 = 848 (0.970)intergenic (+306/+20) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 2247 =117 (1.160)10 (0.020) 3/264 11.2 2.0% intergenic (+27/+141) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?NC_012417 2073 = 848 (0.970)intergenic (+306/+20) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? NC_012417 1976 =968 (1.040)10 (0.010) 6/266 60.0 1.1% intergenic (+209/+117) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
?NC_012417 2035 = 936 (1.060)intergenic (+268/+58) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? NC_012417 1947 =978 (1.050)10 (0.010) 4/264 62.2 1.1% intergenic (+180/+146) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
?NC_012417 2073 = 848 (0.970)intergenic (+306/+20) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein